← FDA Drug Approvals (Drugs@FDA)

CUBICIN

NDA · New Drug Application · Sponsor: CUBIST PHARMS LLC · Approved 2003-09-12

Drug application

FDA Application #

NDA021572

Application type

New Drug Application

Brand name

CUBICIN

Generic name

Daptomycin

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

CUBIST PHARMS LLC

First approval

2003-09-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown